Claims
- 1. Cellulose microfibrils with a modified surface, having hydroxyl functional groups present at the surface etherified by at least one organic compound comprising at least one functional group which reacts with said hydroxyl functional groups and with a degree of surface substitution (DSS) of at least 0.05, said organic compound being a silylating agent, isocyanate, halogenated alkylating agent, alkylene oxide, or glycidyl compound.
- 2. Microfibrils according to claim 1, wherein the silylating agent is: a haloalkylsilane of formula: R3R2R1Si—X, R2R1Si(X)2 or R1Si(X)3;a disilane of formula: R3R2R1N—Si—NR1R2R3; a N-silylacetamide of formula: CH3—CO—NH—SiR1R2R3; or a alkoxysilane of formula: R3R2R1Si—OR or R2R1Si(OR)(OR3); wherein: —R, R1, R2 and R3, which are identical or different, are optionally substituted, saturated or unsaturated, linear, branched or cyclic hydrocarbonaceous radicals having 1 to 30 carbon atoms, and —X is chlorine, bromine or iodine.
- 3. Microfibrils according to claim 2, whern the R, R1, R2 and R3 radicals are methyl, ethyl, propyl, isopropyl butyl, sec-butyl tert-butyl, pentenyl, hexyl cyclohexyl octyl, nonyl, decyl dodecyl, undecyl, nonadecyl, eicosyl (C20), docosyl (C22), octacosyl (C28), triacontanyl (C30), vinyl, allyl, phenyl, styryl or naphthyl.
- 4. Microfibrils according to claim 3, wherein the silylating is chlorodimethylisopropylsilane, chlorodimethylbutylsilane, chlorodimethyloctylsilane, chlorodimethyldodeyilane, chlorodimethyloctadecylsilane, chlordimethylphenylsilane, chloro-(1-hexenyl)dimethylsilane, dichlorohexylmethylsilane, dichloroheptylmethylsilane, trichlorooctylsilane; hexamethyldisilazane, 1,3-divinyl-1,1,3,3-tetramethyldisilazane, 1,3-divinyl-1,3-diphenyl-1,3-dimethyldisilazane, 1,3-N-dioctyltetramethyldisilazane, diisobutyltetramethyldisilazane, diethyltetramethyldisilazane, N-dipropyltetramethyldisilazane, N-dibutyltetramethyldisilazane, 1,3-di(para-tertbutylphenethyl)tetramethyldisilazane; N-trimethylsilylacetamide, N-methyldiphenylsilylacetamide, N-triethylsilylacetamide; tert-butyldiphenylmethoxysilane, octadecyldimethylmethoxysilane, dimethyloctylmethoxysilane, octylmethyldimethoxysilane, octyltrimethoxysilane, trimethylethoxysilane, or octyltriethoxysilane.
- 5. Microfibrils according to claim 1, wherein the halogenated alkylating agent is of formula R4—X, wherein: X is chlorine, bromine or iodine and R4 is an optionally substituted, saturated or unsaturated, linear, branched or cyclic hydrocarbonaceous radicals having 1 to 30 carbon atoms.
- 6. Microfibrils according to claim 5, wherein the halogenated alkylating agent is chloropropane, chlorobutane, bromopropane, bromohexane, bromoheptane, iodomethane, iodoethane, iodooctane, iodooctae or iodobenzene.
- 7. Microfibrils according to claim 1, wherein the isocyanate is of formula R5—NCO, wherein: R5 is an optionally substituted, saturated or unsaturated, linear, branched or cyclic hydrocarbone radicals having 1 to 30 carbon atoms.
- 8. Microfibrils accoding to claim 7, wherein the isocyanate is butyl isocyanate, tert-butyl isocyanate, pentyl isocyanate, octyl isocyanate, dodecyl isocyanate, octadecyl isocyanate or phenyl isocyanate.
- 9. Microfibrils according to claim 1, wherein the alkylene oxide is of formula: wherein: R6 represents an optionally substituted, saturated or unsaturated, linear, branched or cyclic hydrocarbonaceous radicals having 1 to 30 carbon atoms.
- 10. Microfibrils according claim 9, wherein the alkylene oxide is 1,2-epoxybutane, 1,2-epoxyhexane, 1,2-epoxyoctane, 1,2-epoxydecane, 1,2-epoxydodecane, 1,2-epoxyhexadecane, 1,2-epoxyoctadecane or 1,2-epoxy-7-octene.
- 11. Microfibrils according to claim 1, wherein the glycidyl compound is of formula: wherein: R7 represents an optionally substituted, satuared or unsaturated, linear, branched or cyclic hydrocarbonaceous radicals having 1 to 30 carbon atoms.
- 12. Microfibrils according to claim 11, wherein the glycidyl compound is metyl glycidyl ether, propyl glycidyl ether, butyl glycidyl ether, 2-methylbutyl glycidyl ether, ethylhexyl glycidyl ether, octyl glycidyl ether, lauryl glycidyl ether, allyl glycidyl ether or benzyl glycidyl ether.
- 13. A process for the manufacture of cellulose microfibrils with a modified surface as defined in claim 1 from cellulose microfibrils obtained by fibrillation of a material comprising cellulose fibers, said process comprising the steps of:i—wetting or dispersing the cellulose microfibrils in a liquid dispersion medium which does not destroy the cellulose microfibrils, ii—adding, to the dispersion, an agent for the etherification or a mixture of agents for the etherification of the hydroxyl functional groups of the cellulose and optionally a catalyst or an etherification activator and carrying out an etherification reaction, said agent being a silylating agent, isocyanate, halogenated alkylating agent, alkylene oxide, or glycidyl compound, iii—halting the etherification reaction after the desired degree of surface substitution (DSS) has been obtained, and iv—separating the microfibrils obtained in step iii from the liquid medium.
- 14. A process for viscosifying or texturizing a fluid medium or a reinforcing filler comprising the step of adding to said fluid or filler a viscosifying or texturizing amount of microfibrils as defined in claim 1.
- 15. A cosmetic formulation, drilling fluid, paint, glaze, adhesive or ink, comprising a viscosifying amount of microfibrils as defined in claim 1.
- 16. A thermoplastic material thermosetting material, crosslinked elastomer, noncrosslinked elasomer, or mastic comprising a reinforcing amount of microfibrils as defined in claim 1.
- 17. Mirofibrils according to claim 1, wherein the degree of surface substitution (DSS) is between 0.1 and 1.
- 18. Microfibrils according to claim 17, wherein the degree of surface substitution (DSS) is between 0.2 and 0.7.
Priority Claims (1)
Number |
Date |
Country |
Kind |
98 11507 |
Sep 1998 |
FR |
|
Parent Case Info
This application is an application under 35 U.S.C. Section 371 of International Application Number PCT/FR99/02148 filed on Sep. 9, 1999.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/FR99/02148 |
|
WO |
00 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO00/15667 |
3/23/2000 |
WO |
A |
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
6103790 |
Cavaille et al. |
Aug 2000 |
A |